Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20657Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Boletis, J. N. | en |
| dc.contributor.author | Ioannidis, J. P. | en |
| dc.contributor.author | Boki, K. A. | en |
| dc.contributor.author | Moutsopoulos, H. M. | en |
| dc.date.accessioned | 2015-11-24T19:09:07Z | - |
| dc.date.available | 2015-11-24T19:09:07Z | - |
| dc.identifier.issn | 0140-6736 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20657 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adolescent | en |
| dc.subject | Adult | en |
| dc.subject | Cyclophosphamide/*therapeutic use | en |
| dc.subject | Drug Administration Schedule | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Immunoglobulins, Intravenous/*therapeutic use | en |
| dc.subject | Immunosuppressive Agents/*therapeutic use | en |
| dc.subject | Injections, Intravenous | en |
| dc.subject | Lupus Erythematosus, Systemic/drug therapy | en |
| dc.subject | Lupus Nephritis/*drug therapy | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Pilot Projects | en |
| dc.subject | Treatment Outcome | en |
| dc.title | Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1016/S0140-6736(99)01575-5 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/10470708 | - |
| heal.identifier.secondary | http://ac.els-cdn.com/S0140673699015755/1-s2.0-S0140673699015755-main.pdf?_tid=be3a226a6b4f5a61a9ead48527484a4d&acdnat=1333364734_f8fdf130d6fa387ceb2204746b7f3592 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1999 | - |
| heal.abstract | Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard intravenous cyclophosphamide treatment. Pulsed immunoglobulin may be a useful alternative therapy in lupus nephritis. | en |
| heal.journalName | Lancet | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Boletis-1999-Intravenous immunogl.pdf | 37.83 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
